Diagnostic accuracy of C-reactive protein and procalcitonin against blood culture in neonatal sepsis, with ROC/logistic regression analysis and antimicrobial susceptibility pattern: a prospective observational study in a South Indian neonatal intensive care unit
In a prospective study of 200 neonates in a South Indian NICU, procalcitonin demonstrated superior diagnostic accuracy and independent predictive value for blood culture-positive sepsis compared to other markers, while the bacteriological profile was dominated by ESBL-producing *Klebsiella pneumoniae*.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Sepsis is a terrifying condition where the body's immune system goes into overdrive, fighting an infection so fiercely that it begins to damage its own organs. In newborns, this danger is especially acute because their symptoms are often vague and hard to spot; a baby might simply stop feeding, become unusually irritable, or run a fever that is too low or too high. For decades, the only way to confirm sepsis with certainty has been to take a sample of blood and grow any hidden bacteria in a laboratory dish. This process, known as a blood culture, is the gold standard, but it is slow. It can take days to get a result, and by then, a sick baby may have already suffered severe harm. Because of this delay, doctors often have to start powerful antibiotics immediately, guessing at the cause. To help make these decisions faster, medical teams have looked for other clues in the blood, such as C-reactive protein and procalcitonin. These are substances the body releases when it is under stress or fighting an infection. The challenge has been figuring out which of these clues is actually reliable enough to trust when a baby's life is on the line.
In a prospective study conducted over eleven months at a major teaching hospital in southern India, researchers set out to test the reliability of these blood markers against the slow but sure blood culture. They enrolled 200 newborns who showed signs of possible sepsis, such as breathing difficulties, vomiting, or seizures. Before any antibiotics were given, the medical team drew blood from each infant to check for bacteria, measure the levels of C-reactive protein and procalcitonin, and count the white blood cells and platelets. The goal was to see which of these tests could accurately predict whether the blood culture would eventually turn up a dangerous germ. The researchers also took the time to identify exactly which bacteria were causing the infections and tested them against various antibiotics to see which drugs would work and which would fail.
The results painted a clear picture of what works and what does not. Out of the 200 babies, 61 were confirmed to have sepsis based on the blood culture. When the researchers compared the different blood tests, procalcitonin stood out as the most accurate tool. It correctly identified nearly 89 percent of the babies who truly had sepsis and correctly ruled out the disease in nearly 85 percent of those who did not. In contrast, the test for C-reactive protein was less reliable, missing more than a third of the actual cases. The count of white blood cells, a test often used as a first sign of infection, performed no better than a random guess in this group. Perhaps most surprisingly, the researchers found that the number of platelets, the tiny blood cells responsible for clotting, was actually higher in the babies with confirmed sepsis than in those without. This finding runs counter to the common belief that sepsis always causes platelet counts to drop, suggesting that in this specific population, a low platelet count is not a dependable warning sign.
Beyond the blood tests, the study revealed the specific nature of the infections threatening these newborns. The bacteria responsible were overwhelmingly Gram-negative rods, a type of germ that is often harder to treat. The most common culprit was a bacterium called Klebsiella pneumoniae, which accounted for more than half of all the infections found. A significant portion of these bacteria, along with many of the E. coli found, produced a special enzyme that renders common, first-line antibiotics useless. This resistance pattern means that standard treatments often fail, forcing doctors to rely on stronger, reserve medications. The study also identified a specific risk factor: babies born with the help of instruments like forceps or a vacuum were much more likely to have a positive blood culture than those born through normal vaginal delivery or by cesarean section.
The study concludes that for doctors in this region, relying on procalcitonin levels offers a much sharper view of a newborn's condition than looking at white blood cell counts or platelet numbers. Because procalcitonin is so accurate, it could help doctors start the right antibiotics sooner or stop them sooner if the test is negative, reducing the risk of unnecessary drug exposure. However, the researchers caution that the rules for interpreting these tests might need to be adjusted for premature babies, as their procalcitonin levels tend to be naturally higher even without infection. Ultimately, this work provides a clearer path for treating sick newborns, emphasizing the need for rapid, accurate testing and a deep understanding of the local bacteria that are evolving to resist standard medicines.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.